- CEO
- Itaru Tanimura
- Full Time Employees
- 12,100
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Akasaka Intercity Tokyo Japan 107-0052
- IPO Date
- Jun 29, 2020
- Business
- M3, Inc. (MTHRY) provides medical-related services primarily to physicians and other healthcare professionals through Internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, which offers online marketing services including m3.com for healthcare professionals, MR-kun for medical information delivery, QOL-kun for lifestyle support, and AskDoctors for public health queries; Evidence Solutions, which supports clinical trials and research; Career Solutions, which delivers human resources services such as recruitment and job postings via m3.com CAREER for doctors and pharmacists; Site Solutions, which provides operational support including electronic medical records, medical equipment, and home-visit nursing for institutions; Patient Solutions; and Overseas, which delivers similar services in the United States via MDLinx, the United Kingdom via Doctors.net.uk, China, South Korea, India, France, Germany, and Spain. Founded in 2000 and headquartered in Tokyo, Japan, M3 serves pharmaceutical companies, medical institutions, and patients across Japan and internationally, with a focus on digital healthcare marketing, recruitment, research, and clinical support. Recent developments include the August 2025 acquisition by VIDAL Group of GPR, a French prescription support tool for renal failure; the March 2025 acquisition and consolidation of EWEL, Inc.; the February 2025 acquisition of Limbic Digital Media, an Australian medical news provider; and ongoing share repurchases under its articles of incorporation as announced in December 2025, alongside FY2025 Q2 financial results release in November 2025.